Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FQK77
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,605
Award facts
- Contract value 100% obligated
- $12,604.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Skyrizi 360 mg/2.4 mL on-body injectors valued at $12,604.63. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The order is scheduled for completion by May 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. Skyrizi is a prescription biologic medication used to treat inflammatory skin conditions, and this delivery supports the federal medical supply chain requirements of the DLA and associated military healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products, specialty medications, biologics, and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains an extensive portfolio of federal contract awards predominantly with the DLA Medical Supply Chain, demonstrating its capability to meet complex federal procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FQK77?
SPE2DB25FQK77 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FQK77 worth?
The government has obligated $12,605 on SPE2DB25FQK77.
Is contract SPE2DB25FQK77 an order under another contract?
Yes. SPE2DB25FQK77 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQK77 competed?
The extent of competition for SPE2DB25FQK77 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award